Neoplasms

Respiratory Tract (Lung and Bronchial) Diseases

All Conditions

Infections

Symptoms and General Pathology

Lung Neoplasms

COVID-19

Communicable Diseases

Virus Diseases

Coronavirus Infections

Disease Attributes

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Pneumonia

Pneumonia, Viral

Respiratory Tract Infections

Coronaviridae Infections

Nidovirales Infections

RNA Virus Infections

Lung cancer patients infected by COVID-19

IgG test

Mariano Provencio, MD

Observational, retrospective data collection and prospective IgG analysis, and multicenter study.

The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection.

For the identification of patients who contract COVID-19 infection, the IgG+ blood test by ELISA method will be used.

Non-post-authorization study, retrospective of data collection and prospective of IgG analysis, observational and multicenter.

The study will be extended to all the sites of the Spanish Lung Cancer Group, more than 170 centers and 500 professionals, and it is expected that around 1,500 IgG tests will be carried out.

The study has three phases:

The scope of phase I is the identification of acquired immunity (IgG) in patients with lung cancer, whether or not they have presented symptoms of having suffered from COVID19. In addition, the description of the characteristics and evolution of patients with lung cancer who have contracted COVID-19 infection will be carried out.

For the identification of patients who contract COVID-19 infection, the IgG+ test in blood will be used by ELISA method.

The scope of phase II is the confirmation of the presence of antibodies (IgG) in patients who tested positive in Phase I of the study a few weeks after the first diagnosis made through the SOLID study.

The scope of phase III is the confirmation of the presence of antibodies (IgG) in patients with lung cancer who have been vaccinated with any of the available and authorized vaccines for SARS-COV2 and 6 months after said administration.

Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection

Study of Acquired Immunity in Patients With Lung Cancer and COVID-19 Infection

Description of the characteristics and evolution of patients with lung cancer who have contracted COVID-19 infection.

Confirmation of the presence of antibodies (IgG) in patients with lung cancer who have been vaccinated with any of the available and authorized vaccines for SARS-COV2 and 6 months after such administration.

Fundación GECP

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection	NCT04407143	Lung Cancer COVID Corona Virus In...	IgG test	18 Years -	Fundación GECP
Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection	NCT04407143	Lung Cancer COVID Corona Virus In...	IgG test	18 Years -	Fundación GECP

Spots Global Cancer Trial Database for igg test

Every month we try and update this database with for igg test cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for igg test

Every month we try and update this database with for igg test cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for igg test cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.